文献速递头痛与眩晕

慢性偏头痛患者类淋巴与脑膜淋巴功能受损

Impaired Glymphatic and Meningeal Lymphatic Functions in Patients with Chronic Migraine.
PubMed 文献 · Ann Neurol · 2024-01-27

研究前瞻性纳入2020至2023年偏头痛患者与健康对照,用DTI-ALPS指数评估类淋巴功能、动态增强MRI评估脑膜淋巴管功能。慢性偏头痛患者DTI-ALPS值低于发作性偏头痛和健康对照,伴药物过度使用性头痛者更低;慢性偏头痛脑膜淋巴管TTP、EI、MTE均长于发作性偏头痛。MIDAS和PSQI与DTI-ALPS指数负相关。

要点

  • 慢性偏头痛患者DTI-ALPS值低于发作性偏头痛和健康对照。
  • 伴药物过度使用性头痛的慢性偏头痛患者DTI-ALPS值更低。
  • 慢性偏头痛患者脑膜淋巴管TTP、EI、MTE较发作性偏头痛延长。

核心结论

  • 慢性偏头痛患者,尤其伴药物过度使用性头痛者,存在类淋巴和脑膜淋巴功能障碍,具有高度临床相关性,可能涉及偏头痛慢性化的发病机制。

研究设计与样本

  • 前瞻性招募偏头痛患者和健康对照,招募时间为2020年至2023年。
  • 共纳入175名受试者,其中112例偏头痛患者和63名健康对照。
  • 分析发作性偏头痛、慢性偏头痛及伴或不伴药物过度使用性头痛的慢性偏头痛患者的DTI-ALPS指数和动态增强MRI参数(TTP、EI、MTE)。
  • 检查DTI-ALPS指数与临床参数(偏头痛严重程度NRS、残疾MIDAS、躯体疼痛WPI、睡眠质量PSQI)的相关性。

主要发现

  • 慢性偏头痛DTI-ALPS值(中位数[四分位距]=0.64[0.12])低于发作性偏头痛(0.71[0.13],p=0.005)和健康对照(0.71[0.09],p=0.004)。
  • 伴药物过度使用性头痛的慢性偏头痛DTI-ALPS值(0.63[0.07])低于不伴药物过度使用性头痛的慢性偏头痛(0.73[0.12],p<0.001)。
  • 慢性偏头痛较发作性偏头痛paraSSS-mLV的TTP延长(55.8[12.9] vs 40.0[7.6],p<0.001),paraTS-mLV的TTP延长(51.2[8.1] vs 44.0[3.3],p=0.002)。
  • 慢性偏头痛较发作性偏头痛paraSSS-mLV的EI增高(45.5[42.0] vs 16.1[9.2],p<0.001)。
  • 慢性偏头痛较发作性偏头痛paraSSS-mLV的MTE延长(253.7[6.7] vs 248.4[13.8],p<0.001),paraTS-mLV的MTE延长(252.0[6.2] vs 249.7[1.2],p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to investigate migraine glymphatic and meningeal lymphatic vessel (mLV) functions. METHODS: Migraine patients and healthy controls (HCs) were prospectively recruited between 2020 and 2023. Diffusion tensor image analysis along the perivascular space (DTI-ALPS) index for glymphatics and dynamic contrast-enhanced magnetic resonance imaging parameters (time to peak [TTP]/enhancement integral [EI]/mean time to enhance [MTE]) for para-superior sagittal (paraSSS)-mLV or paratransverse sinus (paraTS)-mLV in episodic migraine (EM), chronic migraine (CM), and CM with and without medication-overuse headache (MOH) were analyzed. DTI-ALPS correlations with clinical parameters (migraine severity [numeric rating scale]/disability [Migraine Disability Assessment (MIDAS)]/bodily pain [Widespread Pain Index]/sleep quality [Pittsburgh Sleep Quality Index (PSQI)]) were examined. RESULTS: In total, 175 subjects (112 migraine + 63 HCs) were investigated. DTI-ALPS values were lower in CM (median [interquartile range] = 0.64 [0.12]) than in EM (0.71 [0.13], p = 0.005) and HCs (0.71 [0.09], p = 0.004). CM with MOH (0.63 [0.07]) had lower DTI-ALPS values than CM without MOH (0.73 [0.12], p < 0.001). Furthermore, CM had longer TTP (paraSSS-mLV: 55.8 [12.9] vs 40.0 [7.6], p < 0.001; paraTS-mLV: 51.2 [8.1] vs 44.0 [3.3], p = 0.002), EI (paraSSS-mLV: 45.5 [42.0] vs 16.1 [9.2], p < 0.001), and MTE (paraSSS-mLV: 253.7 [6.7] vs 248.4 [13.8], p < 0.001; paraTS-mLV: 252.0 [6.2] vs 249.7 [1.2], p < 0.001) than EM patients. The MIDAS (p = 0.002) and PSQI (p = 0.002) were negatively correlated with DTI-ALPS index after Bonferroni corrections (p < q = 0.01). INTERPRETATION: CM patients, particularly those with MOH, have glymphatic and meningeal lymphatic dysfunctions, which are highly clinically relevant and may implicate pathogenesis for migraine chronification. ANN NEUROL 2024;95:583-595.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Wu CH, Chang FC, Wang YF, et al. Impaired Glymphatic and Meningeal Lymphatic Functions in Patients with Chronic Migraine. Ann Neurol. 2024. PMID: 38055324. doi:10.1002/ana.26842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。